Pair Name | Silibinin, Trichostatin A | ||
Phytochemical Name | Silibinin (PubChem CID: 31553 ) | ||
Anticancer drug Name | Trichostatin A (PubChem CID: 444732 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Silibinin, Trichostatin A | |||
Disease Info | [ICD-11: 2C10] | Pancreatic cancer | Investigative | |
Biological Phenomena | Induction-->Blockade of cell cycle in G2/M phase | |||
Gene Regulation | Down-regulation | Expression | BIRC5 | hsa332 |
Down-regulation | Expression | CCNA2 | hsa890 | |
In Vitro Model | BxPC-3 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0186 |
PaTu 8988s | Pancreatic adenocarcinoma | Homo sapiens (Human) | CVCL_1846 | |
PANC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0480 | |
Capan-2 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0026 | |
Result | Combination of HDAC inhibitor TSA and silibinin induces cell cycle arrest and apoptosis by targeting survivin and cyclinB1/Cdk1 in pancreatic cancer cells |
Pair Name | Silibinin, Trichostatin A | |||
Disease Info | [ICD-11: 2C25] | Lung cancer | Investigative | |
Biological Phenomena | Induction-->Blockade of cell cycle in G2/M phase | |||
Gene Regulation | Down-regulation | Expression | BCL2 | hsa596 |
Down-regulation | Expression | BCL-xL | hsa598 | |
Down-regulation | Expression | BIRC5 | hsa332 | |
Down-regulation | Expression | CCNB1 | hsa891 | |
Up-regulation | Expression | CDKN1A | hsa1026 | |
Down-regulation | Expression | MCL1 | hsa4170 | |
Down-regulation | Expression | POLD1 | hsa5424 | |
Down-regulation | Expression | XIAP | hsa331 | |
In Vitro Model | NCI-H1299 | Lung large cell carcinoma | Homo sapiens (Human) | CVCL_0060 |
NCI-H358 | Minimally invasive lung adenocarcinoma | Homo sapiens (Human) | CVCL_1559 | |
NCI-H322 | Minimally invasive lung adenocarcinoma | Homo sapiens (Human) | CVCL_1556 | |
In Vivo Model | Six week old athymic (nu/nu) male nude mice were subcutaneously injected with about three million exponentially growing H1299 cells mixed with equal volume (1:1) of matrigel on the right flank of each mouse. | |||
Result | Combinations of TSA with silibinin synergistically augmented the cytotoxic effects of the single agent, which was associated with a dramatic increase in p21 (Cdkn1a) |
No. | Title | Href |
---|---|---|
1 | Combination of HDAC inhibitor TSA and silibinin induces cell cycle arrest and apoptosis by targeting survivin and cyclinB1/Cdk1 in pancreatic cancer cells. Biomed Pharmacother. 2015 Aug;74:257-64. doi: 10.1016/j.biopha.2015.08.017. | Click |
2 | Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells. Epigenetics. 2012 Oct;7(10):1161-72. doi: 10.4161/epi.22070. | Click |